tiprankstipranks
Anson, Cable Car vote against proposed MEI Pharma, Infinity transaction
The Fly

Anson, Cable Car vote against proposed MEI Pharma, Infinity transaction

Anson Funds and Cable Car Capital, collectively the beneficial owners of approximately 14.8% of the outstanding common stock of MEI Pharma, (MEIP), issued the following statement regarding the proposed combination of MEIP and Infinity Pharmaceuticals (INFI): “The Board has forsaken its duty to act in the best interests of stockholders through its misguided focus on the proposed merger with Infinity in the face of vocal opposition from stockholders and a subsequent all-cash acquisition proposal. Additionally, we believe the Board’s determination that our proposed acquisition could not be ‘reasonably expected’ to lead to a superior proposal to the proposed transaction with Infinity is demonstrably incorrect. The Board’s recent steps suggest a desire to continue down a self-serving path of value destruction. In particular, we note the decision to adopt new employment agreements, including a provision that compensates CEO David Urso if ‘rights to the Infinity compound eganelisib are acquired by MEI in 2023 or 2024 in a transaction that is not the Merger.’ This appears to be a blatant attempt to circumvent a potential adverse outcome with respect to the merger vote at the upcoming Special Meeting. We hereby place the Company on notice that if stockholders reject the merger, any subsequent in-licensing or similar transaction would contravene the will of the stockholders and amount to what we believe would be a clear-cut breach of the Board’s duty of care. We intend to take all steps necessary to hold the Board accountable for its actions. Nevertheless, we reiterate our willingness to engage on the terms of our previously communicated proposal to acquire all shares of MEIP not owned by us for not less than $8.00 per share, plus a contingent value right representing the right to receive 80% of the net proceeds from any license or disposition of the Company’s clinical assets. The Acquisition Proposal expires on July 13, 2023 and shall be considered withdrawn, within the meaning of the Infinity merger agreement, if not accepted prior to the stockholders meeting. As we indicated we would, Anson and Cable Car have voted against the proposed combination because we believe it undervalues the Company and will only lead to further value destruction.”

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

See Insiders’ Hot Stocks on TipRanks >>

Read More on MEIP:

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100
Bitcoin

Popular Articles